Cookies Policy
X

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.

I accept this policy

Find out more here

Comparative effect of therapeutic and toxic doses of imipramine administration on the levels of norepinephrine, dopamine and serotonin in discrete regions of rat brain

No metrics data to plot.
The attempt to load metrics for this article has failed.
The attempt to plot a graph for these metrics has failed.
The full text of this article is not currently available.

Brill’s MyBook program is exclusively available on BrillOnline Books and Journals. Students and scholars affiliated with an institution that has purchased a Brill E-Book on the BrillOnline platform automatically have access to the MyBook option for the title(s) acquired by the Library. Brill MyBook is a print-on-demand paperback copy which is sold at a favorably uniform low price.

This Article is currently unavailable for purchase.
Add to Favorites
You must be logged in to use this functionality

Levels of norepinephrine (NE), dopamine (DA) and 5-hydroxytryptamine (5-HT) were estimated by HPLC in different regions of adult rat brain after feeding therapeutic (25 mg/kg) or toxic (100 mg/kg) doses of imipramine for 60 days. Imipramine (25 mg/kg) significantly enhanced the growth rate compared to control but the 100 mg/kg dose significantly reduced the body growth rate (but not brain weight) and in addition induced tremors, lethargy, hyperpigmentation and alopecia.

Imipramine, 25 mg/kg, consistently decreased the levels of NE in cortex, striatum-accumbens, cerebellum and brainstem by about 24% (p < 0.01) and decreased DA levels in cortex, hippocampus and hypothalamus (p = 0.01). 5-HT levels were decreased in cortex, striatum-accumbens, hippocampus and brainstem by about 20% (p < 0.01) in imipramine-treated rats. On the contrary, 100 mg/kg of imipramine consistently increased NE levels in cortex, striatum-accumbens, hypothalamus (p < 0.01) and cerebllum (p < 0.05) and increased DA levels only in cerebllum by 39% (p = 0.01). Increased 5-HT levels were seen in all brain regions, of imipraminefed rats, by about 20% (p < 0.01). This study shows that the effects of imipramine on monoamine levels in brain is both region specific and dose dependent. The results suggest that decreased monoamine levels at 25 mg/kg of imipramine in humans might be responsible for the antidepressant effect of imipramine, and increased monoamine levels at higher doses might be responsible for various CNS toxic symptoms observed in patients with high doses of imipramine.

10.1163/1569391053123309
/content/journals/10.1163/1569391053123309
dcterms_title,pub_keyword,dcterms_description,pub_author
10
5
Loading
Loading

Full text loading...

/content/journals/10.1163/1569391053123309
Loading

Data & Media loading...

http://brill.metastore.ingenta.com/content/journals/10.1163/1569391053123309
Loading

Article metrics loading...

/content/journals/10.1163/1569391053123309
2017-10-20

Sign-in

Can't access your account?
  • Key

  • Full access
  • Open Access
  • Partial/No accessInformation